2021 annual financial data
Bionano Genomics 2021 Operating margin
Direct answer
Operating margin was -428.79%.
Operating income was -77.1M USD and net income was -72.44M USD.
Operating cash flow was -71.93M USD.
Get free Bionano Genomics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 17.98M USD
- Operating income
- -77.1M USD
- Net income
- -72.44M USD
- Operating cash flow
- -71.93M USD